Revistas
Revista:
ANALES DEL SISTEMA SANITARIO DE NAVARRA
ISSN:
1137-6627
Año:
2022
Vol.:
45
N°:
1
Págs.:
e0953
Background. The diagnostic accuracy of bone scintigraphy (BS) increases with SPECT/CT imaging. It would therefore be appropriate to reassess the diagnostic utility of scintigraphy in sacroiliitis with axial spondyloarthritis (SpA). The aim of this study was to compare the diagnostic performance of MRI, SPECT/CT and a combination of both techniques in sacroiliitis, and to evaluate the correlation between quantitative SPECT/CT indices and quantitative MRI inflammatory lesion scores. Methods. Thirty-one patients with active SpA and 22 patients with inflammatory low back pain underwent MRI and SPECT/ CT of the sacroiliac joints. The diagnostic accuracy of both techniques was calculated using clinical diagnosis as the gold standard. The correlation between MRI and SPECT/CT was calculated by comparing the SPECT/CT activity indices and the Berlin/ SPARCC scoring systems for MRI. Results. The sensitivity and specificity values in quantitative SPECT/CT, taking the sacroiliac/promontory ratio of >1.36 as the cut-off value, were close to those from MRI published in the literature. The combination of both techniques increased sensitivity while maintaining high specificity. There was a moderate correlation between SPECT/CT and MRI total scores. This correlation was improved by using solely the MRI inflammation scores. Conclusion. Quantitative SPECT/CT showed better diagnostic accuracy than planar scintigraphy and showed a moderate correlation with MRI scores in active sacroiliitis. The combination of both tests increased the diagnostic accuracy. Quantitative SPECT/CT could play a relevant role in the diagnosis of active sacroiliitis in patients with high a suspicion of SpA and a negative/inconclusive MRI test or in patients with whom MRI studies cannot be carried out. Keywords. Diagnoses. Sacroiliitis. Spondyloarthritis. Bone scintigraphy. Magnetic resonance imaging.
Revista:
REUMATOLOGIA CLINICA
ISSN:
1699-258X
Año:
2019
Vol.:
15
N°:
5
Págs.:
307 - 308
Revista:
JOURNAL OF TRANSLATIONAL MEDICINE
ISSN:
1479-5876
Año:
2016
Vol.:
14
N°:
1
Págs.:
246
The single intraarticular injection of in vitro expanded autologous BM-MSCs together with HA is a safe and feasible procedure that results in a clinical and functional improvement of knee OA, especially when 100 × 10(6) cells are administered. These results pave the way for a future phase III clinical trial.
Revista:
BRITISH JOURNAL OF DERMATOLOGY
ISSN:
0007-0963
Año:
2015
Vol.:
172
N°:
5
Págs.:
1442-1445
Revista:
ANALES DEL SISTEMA SANITARIO DE NAVARRA
ISSN:
1137-6627
Año:
2014
Vol.:
37
N°:
3
Págs.:
439 - 440
Revista:
ACTAS DERMO-SIFILIOGRAFICAS
ISSN:
0001-7310
Año:
2013
Vol.:
104
N°:
5
Págs.:
380-92
Rituximab was introduced into clinical practice as a medication with considerable potential. Its use in patients with B-cell lymphoma and rheumatoid arthritis revealed numerous indications in autoimmune diseases, many of which involve the skin, thus requiring dermatologists to become familiar with both the characteristics of anti-CD20 antibodies and the role of B cells in multiple skin diseases. Thanks to these developments, we will be able to use rituximab more frequently and appropriately in our patients and draw up consensus guidelines based on large case series. In other words, establishing the indications for rituximab will make it possible to shorten disease course and reduce morbidity due to more specific drugs.
Revista:
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
ISSN:
1201-9712
Año:
2012
Vol.:
17
N°:
2
Págs.:
e132-3
Listeriosis can be a cause of arthritis. Here, we present a case of Listeria monocytogenes septic arthritis of the right hip in a 66-year-old male treated with mycophenolate mofetil for polyarteritis nodosa. So far, septic arthritis due to this microorganism has not been reported in patients treated with mycophenolate mofetil. We review the literature of L. monocytogenes septic arthritis and discuss the role of mycophenolate mofetil treatment in precipitating listeriosis.
Capítulos de libros
Libro:
Balcells. La clínica y el laboratorio.
Lugar de Edición:
Barcelona
Editorial:
Elsevier
Año:
2019
Págs.:
927 - 936
Libro:
Balcells. La clínica y el laboratorio.
Lugar de Edición:
Barcelona
Editorial:
Elsevier
Año:
2019
Págs.:
781 - 790
Libro:
Balcells. La clínica y el laboratorio
Lugar de Edición:
Barcelona
Editorial:
Elsevier
Año:
2019
Págs.:
273 - 279
Libro:
Guía de actuación en Urgencias
Lugar de Edición:
Pamplona
Editorial:
CUN
Año:
2018
Págs.:
233 - 241
Libro:
La clínica y el laboratorio. 22ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2015
Págs.:
873-882
Libro:
La clínica y el laboratorio. 22ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2015
Págs.:
741-750
Libro:
La clínica y el laboratorio. 22ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2015
Págs.:
267-275
Libro:
La Clínica y el Laboratorio. 21.ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2010
Págs.:
753-761
Libro:
La Clínica y el Laboratorio. 21.ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2010
Págs.:
647-654
Libro:
La Clínica y el Laboratorio. 21.ª ed
Lugar de Edición:
Barcelona
Editorial:
Editorial MASSON S.A
Año:
2010
Págs.:
243-247
Nacionales y Regionales
Título:
Aplicaciones del estudio multi-ómico de la microbiota al desarrollo de soluciones biotecnológicas innovadoras en el área de la salud (microBiomics)
Código de expediente:
0011-1411-2021-000106
Investigador principal:
María Teresa Herráiz Bayod
Financiador:
GOBIERNO DE NAVARRA
Convocatoria:
2021 GN PROYECTOS ESTRATEGICOS DE I+D 2021-2024
Fecha de inicio:
15/04/2021
Fecha fin:
31/12/2023
Importe concedido:
366.577,17€
Otros fondos:
-
Otros (PIUNA, fundaciones, contratos…)
Título:
REGISPON-3: Seguimiento del Registro Español de Espondiloart
Investigador principal:
Enrique Tomás Ornilla Laraudogoitia
Fecha de inicio:
15/07/2021
Fecha fin:
20/07/2023
Importe:
620,00€
Otros fondos: